SHW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sherwin-Williams is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants an immediate decision. The business is high quality and long-term attractive, but the current setup is mixed: momentum is strong, yet the stock is technically overbought, analysts are split, insider selling is elevated, and the near-term trading pattern suggests weaker returns over the next week to month. I would not call this a clean buy today; hold and wait for a better entry is the stronger call.
SHW closed at 352.98, slightly above the prior close, and is trading near resistance. MACD histogram is positive and expanding, which supports the current uptrend. However, RSI_6 at 86.738 is deeply overbought, signaling stretched short-term conditions. Moving averages are converging, so trend strength is present but not yet strongly confirmed for a fresh entry. Key levels: pivot 334.571, R1 348.953, R2 357.838. The stock is already above R1 and approaching R2, so upside from here looks limited in the immediate term. The pattern-based forecast also points to modest next-day upside but weakness over the next week and month.
Positive catalysts include Citi raising its price target to $380 and keeping a Buy rating, Citi’s view that current levels are attractive, and the company’s strong long-term positioning in housing, repaint, and market share gains. The news also shows a new digital payment partnership with Square for the PRO+ customer program, which supports customer engagement. Congress trading data is also supportive, with 2 purchase transactions versus 1 sale, indicating net positive political sentiment. Financially, the latest reported quarter showed about 2% revenue growth to $23.6 billion and net income of $2.6 billion, showing continued profitability and stability.
Negative catalysts include UBS downgrading the stock to Neutral with a much lower target of $330, reflecting concern about the weak housing backdrop and delayed earnings acceleration. BMO also cut its target to $355 from $420 due to a tougher macro environment, higher raw materials, and housing weakness. Insider selling has increased sharply by 277.59% over the last month, which is a negative signal. The options tape is also defensive, with a very high daily put-volume skew. The stock trend model suggests negative performance over the next week and month. Analyst views remain mixed, with some upsides but clear near-term concern around housing and growth timing.
The latest quarter information available points to modest growth rather than rapid acceleration. Sherwin-Williams reported approximately 2% revenue growth to $23.6 billion and net income of $2.6 billion, which confirms strong profitability but only slow top-line growth. For a company with Sherwin-Williams' quality profile, the latest quarter season indicates stable fundamentals, but not a strong earnings-growth breakout.
Analyst sentiment has turned more mixed recently. Citi is bullish, raising its target to $380 and reiterating Buy, while Evercore and JPMorgan remain constructive with targets around $390-$400 and Overweight/Outperform views. On the bearish side, UBS downgraded to Neutral and cut target to $330, and BMO also reduced its target to $355 due to weak housing and raw-material pressure. Wall Street’s pros: strong brand, pricing power, market share gains, and long-term recovery potential. Cons: housing softness, slower EPS growth, and limited near-term catalysts. Overall, pros are longer-term and the cons dominate the immediate setup.
